Related Experiment Video
Updated: Oct 15, 2025

Author Spotlight: Advancing Research Through Single Cell Sequencing and Spatial Histology in Placental Tissues
Published on: September 8, 2023
Novel Human Placenta-Based Extract for Vascularization Strategies in Tissue Engineering
Johannes Hackethal1,2, Anna Maria Weihs2,3, Lisa Karner1,2
1Ludwig Boltzmann Institute for Experimental and Clinical Traumatology in AUVA Trauma Research Center, Vienna, Austria.
Researchers developed a human placenta substrate (hpS) for tissue engineering. This new biomaterial effectively promotes blood vessel formation in vitro, offering a promising alternative to animal-derived products for regenerative medicine.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Regenerative Medicine
- Vascular Biology
Background:
- Critical need for vascularized tissues in regenerative medicine and organ replacement.
- Limitations of current 2D and 3D in vitro neovascularization assays in mimicking native tissue extracellular matrix (ECM).
- Matrigel, a common animal-derived ECM product, faces translation challenges due to its xenogenic origin and potential immune reactions.
Purpose of the Study:
- To develop an effective method for isolating a human-derived substrate (hpS) for in vitro neovascularization.
- To characterize the hpS and evaluate its potential as a biomaterial for vascularization strategies in tissue engineering.
- To compare the vasculogenic potential of hpS with Matrigel in 2D and 3D in vitro models.
Main Methods:
- Isolation and biochemical characterization of human placenta substrate (hpS) using BCA assay, DNA/GAG content analysis, SDS-PAGE, Western blot, angiogenesis arrays, thrombin detection, HPLC, and antimicrobial assessment.
- 2D in vitro cell culture experiments using gfpHUVECs to assess vasculogenic potential and network complexity on hpS compared to Matrigel.
- 3D in vitro vasculogenesis assays by solidifying hpS with natural polymers (e.g., fibrinogen) and seeding gfpHUVECs.
Main Results:
- hpS induced spontaneous formation of interconnected networks of human umbilical vein endothelial cells (gfpHUVECs) in vitro.
- 2D cultures on hpS demonstrated significantly higher network complexity (tubules, junctions, tube length) compared to Matrigel.
- 3D hpS-based constructs supported in vitro vasculogenesis, indicating potential for in vivo applications.
Conclusions:
- Human placenta substrate (hpS) is a potent, human-derived biomaterial for promoting vascularization.
- hpS offers a viable, xenogenic-free alternative to animal-derived matrices like Matrigel for tissue engineering applications.
- This study highlights hpS as a promising substrate for developing vascularized tissues and organs.
More Related Videos
05:30Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis
Published on: November 8, 2024
04:41Author Spotlight: Improving Reproducibility in Vascular Organoids Using ROCK Inhibitors and Microwell Confinement
Published on: December 13, 2024